New drugs do not fall from the sky. Their development has become a complex, expensive, and multidimensional process. There is the past without which we cannot understand the present; the present which this book discusses; and the future. We can extrapolate some technical developments, such as the expanding technique of microencapsulation. The more complex other dimensions are, the more difficult it is to make predictions, specifically where there are interfaces between politics, weltanschauung, and technical developments. Adolescents are legally still children, but no longer physiologically. Adolescents and prepubertal older school children rarely need age-appropriate pediatric formulations. Pointless and/or exaggerated “pediatric” clinical studies in this age group need to be challenged by those working in pharmaceutical development. Formulation development for the benefit of young and very young children and babies is probably the most valuable aspect of pediatric legislation.